Metolazon Abcur (Metolazone)
Thiazide-like diuretic for refractory edema in kidney disease
Metolazon Abcur is a prescription diuretic containing metolazone 5 mg. It is used to treat edema (fluid retention) associated with kidney disease when other diuretics have not been sufficiently effective. Unlike standard thiazide diuretics, metolazone maintains its efficacy even in patients with significantly reduced kidney function, making it a valuable option for managing refractory edema.
Quick Facts
Key Takeaways
- Metolazon Abcur is a thiazide-like diuretic that remains effective in patients with reduced kidney function, unlike conventional thiazide diuretics.
- The starting dose is 2.5 mg daily, taken with the same meal each day. The tablet can be halved along its score line.
- Regular blood tests to monitor electrolytes (especially potassium, sodium, and magnesium) are essential during treatment.
- Metolazone has significant interactions with lithium, digoxin, and loop diuretics – always inform your prescriber of all medications you take.
- Do not use during pregnancy or breastfeeding. Seek immediate medical attention if you experience vision changes or eye pain during treatment.
What Is Metolazon Abcur and What Is It Used For?
Metolazon Abcur belongs to a class of medicines known as thiazide-like diuretics. While it shares a similar mechanism of action with traditional thiazide diuretics such as hydrochlorothiazide, metolazone has a distinct advantage: it retains significant diuretic activity in patients with impaired renal function, including those with a glomerular filtration rate (GFR) below 30 mL/min. This property makes it an important therapeutic tool in the management of resistant edema associated with chronic kidney disease (CKD).
Metolazone works by blocking the reabsorption of sodium and chloride ions in the distal convoluted tubule of the kidney. This action promotes the excretion of excess sodium, chloride, potassium, and water, thereby reducing fluid retention and the associated symptoms such as swelling in the legs, ankles, and feet. The reduction of extracellular fluid volume also helps to lower blood pressure, although metolazone is primarily prescribed for its diuretic rather than its antihypertensive effect in the context of Metolazon Abcur.
In clinical practice, metolazone is frequently used as an adjunct to loop diuretics (such as furosemide) in patients with diuretic resistance – a condition where the kidneys no longer respond adequately to a single class of diuretic. This combination, known as sequential nephron blockade, targets different parts of the kidney tubule and can produce a powerful diuretic response. However, this approach requires careful medical supervision due to the risk of severe electrolyte disturbances and dehydration.
The active substance in this medicine, metolazone, may also be approved for other medical conditions not described in this information. Always follow your healthcare provider’s instructions and consult them if you have any questions about your treatment.
What Should You Know Before Taking Metolazon Abcur?
Contraindications
You must not take Metolazon Abcur if any of the following apply to you:
- Allergy to metolazone or any other ingredient in this medicine (see the composition section for a full list of ingredients).
- History of allergic reaction to sulfonamide or thiazide diuretics – these drugs share structural similarities and cross-reactivity can occur.
- Anuria – inability to produce urine, which indicates severe kidney failure where the drug cannot exert its effect.
- Hepatic coma or pre-coma associated with liver cirrhosis – diuretics can worsen electrolyte imbalances that contribute to hepatic encephalopathy.
- Severe electrolyte disturbances – uncorrected hyponatremia, hypokalemia, or hypercalcemia must be addressed before initiating treatment.
Warnings and Precautions
Talk to your doctor or pharmacist before taking Metolazon Abcur if you have:
- Kidney disease – while metolazone works in reduced kidney function, careful monitoring of renal parameters is essential. Your doctor will regularly check your blood urea nitrogen (BUN) and serum creatinine levels.
- Diabetes mellitus – metolazone can impair glucose tolerance and may increase blood sugar levels. Patients with diabetes may need adjustment of their insulin or oral antidiabetic medication.
- Gout or elevated uric acid levels – thiazide-like diuretics reduce uric acid excretion and may trigger gout attacks. Regular monitoring of uric acid levels is recommended.
- Systemic lupus erythematosus or other rheumatic conditions – there have been reports of exacerbation of these conditions with thiazide-type diuretics.
If you experience decreased vision or eye pain after starting Metolazon Abcur, seek medical attention immediately. These may be symptoms of choroidal effusion (fluid accumulation between the choroid and sclera) or acute angle-closure glaucoma, which can develop within hours to weeks of starting treatment. Untreated, this condition can lead to permanent vision loss. Patients with a history of penicillin or sulfonamide allergy may be at higher risk.
If you develop signs of infection such as fever, sore throat, mouth ulcers, or difficulty urinating, contact your doctor promptly. In rare cases, metolazone can reduce white blood cell count (agranulocytosis), weakening your immune defense. A blood test will be required to rule out this condition.
If you are scheduled for surgery, your dose of Metolazon Abcur may need to be carefully adjusted. Inform your surgeon and anesthetist that you are taking this medication, as it can affect blood pressure regulation and electrolyte balance during surgical procedures.
Pregnancy and Breastfeeding
Metolazon Abcur should not be used during pregnancy. Metolazone may cross the placental barrier and could potentially cause fetal harm, including electrolyte imbalances and reduced placental perfusion. If you are pregnant, think you may be pregnant, or are planning to have a baby, consult your doctor before taking this medicine. Alternative treatments with a more established safety profile during pregnancy should be considered.
Metolazone is excreted in breast milk and should not be used during breastfeeding. The drug could reduce milk production and may affect the nursing infant. If treatment with metolazone is necessary, breastfeeding should be discontinued.
Driving and Operating Machinery
No formal studies have been conducted on the effects of Metolazon Abcur on the ability to drive or use machines. However, treatment may cause side effects such as dizziness, fatigue, and drowsiness, particularly at the start of therapy or when the dose is adjusted. If you experience these effects, do not drive or operate machinery until you know how this medicine affects you. You are personally responsible for assessing your fitness to drive or perform tasks requiring alertness.
Important Information About Excipients
Metolazon Abcur contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. The medicine also contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially sodium-free.
Alcohol
If you consume alcohol while taking Metolazon Abcur, you may experience an additional decrease in blood pressure. This can lead to dizziness, weakness, and fatigue. It is advisable to limit alcohol consumption during treatment and to be cautious when standing up from a sitting or lying position.
How Does Metolazon Abcur Interact with Other Drugs?
Drug interactions with metolazone can be serious and potentially life-threatening. Before starting treatment, provide your doctor or pharmacist with a complete list of all medicines you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. The following interactions are of particular clinical importance:
Major Interactions
| Interacting Drug | Effect | Clinical Action |
|---|---|---|
| Lithium | Reduced renal clearance of lithium leading to increased serum lithium levels and risk of lithium toxicity | Monitor lithium levels closely; dose adjustment likely needed |
| Digoxin | Metolazone-induced hypokalemia increases sensitivity to digoxin toxicity (arrhythmias) | Monitor potassium levels; consider potassium supplementation |
| Loop diuretics (furosemide, bumetanide) | Synergistic diuretic effect causing profound electrolyte depletion, dehydration, and hypotension | Close monitoring of electrolytes, renal function, and volume status; use lowest effective doses |
| Cyclosporine | Increased risk of hyperuricemia and gout complications | Monitor uric acid levels; watch for signs of gout |
| Sotalol | Hypokalemia and hypomagnesemia increase risk of QT prolongation and torsades de pointes | Maintain potassium above 4.0 mmol/L; ECG monitoring advisable |
Other Important Interactions
| Interacting Drug | Effect | Clinical Action |
|---|---|---|
| NSAIDs (ibuprofen, naproxen) | Reduced diuretic and antihypertensive effect; increased risk of kidney injury | Avoid prolonged use; monitor renal function if combined |
| ACE inhibitors (enalapril, ramipril) | Risk of first-dose hypotension, especially in volume-depleted patients | Start ACE inhibitor at a low dose; consider holding metolazone for 2–3 days before initiation |
| Angiotensin II antagonists (losartan, valsartan) | Enhanced hypotensive effect and risk of renal impairment | Monitor blood pressure and renal function closely |
| Insulin / oral antidiabetics | Impaired glucose tolerance; may require dose adjustment of antidiabetic treatment | Monitor blood glucose more frequently at start of treatment |
| Warfarin | Possible alteration of anticoagulant effect | Monitor INR closely when starting or stopping metolazone |
| Corticosteroids / ACTH | Increased risk of hypokalemia due to additive potassium-wasting effects | Monitor potassium levels; supplement as needed |
| Barbiturates | Enhanced orthostatic hypotension | Rise slowly from sitting or lying positions; monitor blood pressure |
What Is the Correct Dosage of Metolazon Abcur?
Always take Metolazon Abcur exactly as your doctor has told you. If you are unsure, check with your doctor or pharmacist. The dose is individualized based on your medical condition, kidney function, and clinical response. The following dosage information provides general guidance, but your doctor’s specific instructions should always take precedence.
Adults
Standard Dosing – Adults
- Initial dose: 2.5 mg (half a tablet) once daily
- Dose adjustments: Your doctor may increase the dose based on your individual response and electrolyte levels
- Maximum dose: Determined by your doctor based on clinical response and tolerability
- Timing: Take the tablet at the same meal each day, preferably breakfast, to minimize nighttime urination
The Metolazon Abcur 5 mg tablet features a score line on one side, allowing it to be divided into two equal 2.5 mg halves. This facilitates precise dose titration. When combining metolazone with a loop diuretic for refractory edema, your doctor may prescribe metolazone to be taken 30–60 minutes before the loop diuretic to optimize the synergistic effect.
Children
The use of Metolazon Abcur in children has not been well established. This medication is generally not recommended for pediatric patients unless specifically prescribed by a specialist. If your child has been prescribed metolazone, follow the specialist’s dosing instructions exactly.
Elderly Patients
Elderly patients are more susceptible to the effects of diuretics, including electrolyte imbalances and dehydration. Treatment should be initiated at the lowest effective dose, and careful monitoring of kidney function, electrolytes, and blood pressure is particularly important. Orthostatic hypotension (a sudden drop in blood pressure upon standing) is more common in older adults and may increase the risk of falls.
Missed Dose
If you forget to take Metolazon Abcur, take it as soon as you remember, unless it is close to the time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a forgotten tablet.
Overdose
If you or someone else has taken too much Metolazon Abcur, contact a doctor, hospital, or poison control center immediately. Symptoms of overdose may include excessive thirst, nausea, vomiting, disorientation, drowsiness, muscle cramps, and low blood pressure. In severe cases, overdose can cause cardiac arrhythmias (irregular heartbeat), which can be life-threatening.
What Are the Side Effects of Metolazon Abcur?
Like all medicines, Metolazon Abcur can cause side effects, although not everybody gets them. Most side effects are related to the drug’s diuretic action and its effects on electrolyte balance. Your doctor will monitor your blood tests regularly to detect any electrolyte abnormalities early.
Contact your doctor immediately or go to the nearest emergency department if you experience:
- Flu-like symptoms, sore throat, mouth ulcers, or difficulty urinating – these may indicate agranulocytosis (severe reduction in white blood cells), which is rare but potentially life-threatening.
- Severe skin reaction starting with painful skin redness progressing to large blisters and skin peeling – this may be toxic epidermal necrolysis (TEN), a medical emergency.
- Decreased vision or eye pain – possible signs of choroidal effusion or acute angle-closure glaucoma.
Side Effects by Frequency
Common
May affect up to 1 in 10 people
- Nausea, vomiting, constipation, and diarrhea
- Muscle cramps
- Headache, dizziness, and fatigue
- Low potassium levels (hypokalemia)
- Low sodium levels (hyponatremia)
- Low chloride levels (hypochloremia)
- Elevated uric acid, urea, and creatinine in blood
- Elevated blood sugar (hyperglycemia)
- Glucose in urine (glycosuria)
Uncommon
May affect up to 1 in 100 people
- Decreased white blood cell count (leukopenia)
- Skin rash
- Inflammation of blood vessels (vasculitis)
- Gout
Rare
May affect up to 1 in 1,000 people
- Decreased red blood cell count (anemia)
- Decreased platelet count (thrombocytopenia)
- Elevated calcium levels in blood (hypercalcemia)
- Low magnesium levels (hypomagnesemia)
- Hepatitis or intrahepatic cholestasis (liver inflammation or bile flow obstruction)
- Kidney failure
- Agranulocytosis (severe reduction in white blood cells)
- Toxic epidermal necrolysis (severe skin reaction)
Not Known
Frequency cannot be estimated from available data
- Decreased vision or eye pain due to increased eye pressure (possible choroidal effusion or acute angle-closure glaucoma)
Electrolyte Monitoring
Many of the side effects of metolazone are related to electrolyte imbalances. Your doctor will regularly monitor your blood levels of potassium, sodium, magnesium, calcium, uric acid, blood glucose, and kidney function markers (creatinine and BUN). If you experience symptoms such as muscle weakness, cramps, irregular heartbeat, excessive thirst, confusion, or unusual fatigue, contact your doctor as these may indicate electrolyte disturbances.
Hypokalemia (low potassium) is particularly important to monitor because it can increase the risk of dangerous cardiac arrhythmias, especially in patients also taking digoxin or other drugs that prolong the QT interval. Your doctor may recommend potassium-rich foods (bananas, oranges, potatoes, spinach) or prescribe potassium supplements to prevent this complication.
Reporting Side Effects
If you experience any side effects, talk to your doctor or pharmacist. You can also report side effects directly to your national pharmacovigilance agency. By reporting side effects, you help provide more information on the safety of this medicine.
How Should You Store Metolazon Abcur?
Proper storage of Metolazon Abcur is important to maintain the quality and effectiveness of the medicine. Follow these storage guidelines:
- Keep out of sight and reach of children. Store in a location that is inaccessible to young children.
- Store in the original packaging to protect the tablets from light, as metolazone is light-sensitive.
- Do not use after the expiry date printed on the carton after “EXP.” The expiry date refers to the last day of the stated month.
- No special temperature conditions are required, but store at room temperature away from excessive heat and moisture.
- Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures help to protect the environment.
What Does Metolazon Abcur Contain?
Active Ingredient
Each tablet contains metolazone 5 mg as the active substance responsible for the therapeutic effect.
Inactive Ingredients (Excipients)
| Ingredient | Function |
|---|---|
| Croscarmellose sodium | Disintegrant – helps the tablet break apart for absorption |
| Microcrystalline cellulose | Binder/filler – provides structure and bulk |
| Lactose monohydrate | Filler – provides bulk to the tablet |
| Sodium stearyl fumarate | Lubricant – prevents sticking during manufacturing |
Appearance and Packaging
Metolazon Abcur tablets are round, flat, white to off-white in color, with beveled edges and a score line on one side. The tablet can be divided into two equal halves of 2.5 mg each. They are supplied in blister packs of 20, 28, 30, 50, 56, 60, 98, or 100 tablets. Not all pack sizes may be marketed in every country.
Frequently Asked Questions About Metolazon Abcur
While both are thiazide-type diuretics, metolazone has a key advantage: it remains effective in patients with significantly reduced kidney function (GFR below 30 mL/min), whereas hydrochlorothiazide loses much of its efficacy at low GFR levels. This makes metolazone particularly useful for patients with chronic kidney disease who need diuretic therapy. Metolazone also has a longer duration of action (12–24 hours compared to 6–12 hours for hydrochlorothiazide) and is more potent on a milligram-for-milligram basis.
Yes, metolazone is frequently combined with loop diuretics such as furosemide in clinical practice, particularly for resistant edema. This combination is known as sequential nephron blockade and can produce a very powerful diuretic response. However, this must be done under close medical supervision because the combination significantly increases the risk of dehydration, severe electrolyte disturbances (especially hypokalemia and hyponatremia), and acute kidney injury. Daily weight monitoring and regular blood tests are essential.
Metolazone typically begins to produce a diuretic effect within 1–2 hours of oral administration, with the peak effect occurring at approximately 2–8 hours. The full clinical benefit for edema control may take several days to weeks to become apparent, depending on the severity of fluid retention and the patient’s kidney function. When used in combination with a loop diuretic, the synergistic diuretic response is usually seen within the first 24–48 hours.
Because metolazone can cause potassium loss, your doctor may recommend eating potassium-rich foods such as bananas, oranges, potatoes, spinach, and avocados. However, do not take potassium supplements without medical advice, as excessive potassium can also be dangerous, especially if you are taking other medications that affect potassium levels (such as ACE inhibitors). Limit alcohol consumption as it can enhance the blood pressure-lowering effect and cause dizziness. Maintain adequate fluid intake unless your doctor advises otherwise.
You should not stop taking metolazone suddenly without consulting your doctor. Abruptly discontinuing a diuretic can lead to rapid fluid reaccumulation (rebound edema), particularly in patients with heart failure or kidney disease. Your doctor will advise you on how to gradually reduce the dose if discontinuation is appropriate. If you experience significant side effects that concern you, contact your doctor before stopping the medication.
Metolazone can be used in patients with diabetes, but it requires careful monitoring of blood glucose levels. Thiazide-like diuretics can impair glucose tolerance and may raise blood sugar levels, potentially worsening diabetic control. Your doctor may need to adjust the dose of your insulin or oral antidiabetic medication. Regular HbA1c monitoring is advisable during treatment. The benefits of effective edema control must be weighed against the metabolic effects of the drug.
References and Medical Sources
- European Medicines Agency (EMA). “Metolazone – Summary of Product Characteristics.” EMA product database. Accessed January 2026.
- British National Formulary (BNF). “Metolazone.” NICE BNF, 2025. bnf.nice.org.uk
- KDIGO (Kidney Disease: Improving Global Outcomes). “Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.” Kidney International Supplements, 2024.
- Ellison DH, Felker GM. “Diuretic Treatment in Heart Failure.” New England Journal of Medicine. 2017;377(20):1964–1975. DOI: 10.1056/NEJMra1703100
- Brater DC. “Pharmacology of Diuretics.” American Journal of the Medical Sciences. 2000;319(1):38–50.
- World Health Organization (WHO). “WHO Model List of Essential Medicines – 23rd List, 2023.” Geneva: WHO, 2023.
- Jentzer JC, DeWald TA, Hernandez AF. “Combination of Loop Diuretics with Thiazide-Type Diuretics in Heart Failure.” Journal of the American College of Cardiology. 2010;56(19):1527–1534.
- Sica DA. “Metolazone and Its Role in Edema Management.” Congestive Heart Failure. 2003;9(2):100–105.
About the Medical Editorial Team
This article has been reviewed by iMedic’s Medical Editorial Team, which consists of licensed physicians with specializations in nephrology, clinical pharmacology, and internal medicine. Our editorial process follows the GRADE framework for evidence assessment, and all medical claims are supported by peer-reviewed research and international clinical guidelines.
All content is reviewed by board-certified physicians with expertise in nephrology and pharmacology. Our team follows EMA, BNF, and KDIGO guidelines for medication information.
We adhere to Evidence Level 1A standards, basing our information on systematic reviews, meta-analyses, and randomized controlled trials published in peer-reviewed journals.
iMedic receives no funding from pharmaceutical companies. All content is editorially independent. We have no conflicts of interest to declare regarding this medication.